Towa International is the international hub of Towa Pharmaceutical, a leading generic company in Japan. Towa International is dedicated to the research, development, manufacturing, marketing, and distribution of generic and value-added medicines, with the aim of contributing to improving people's health. It is headquartered in Barcelona, where it has an R&D Center and a state-of-the-art manufacturing plant. The company operates with four independent business units that complement each other. These units respond to business and regulatory needs: Towa US - Breckenridge Pharmaceutical, with offices in New Jersey; Towa EU (Towa Pharmaceutical Italy, Spain, and Portugal), with offices in Milan, Barcelona and Lisbon; Towa 2B (worldwide); and the recently launched CMO/CDMO unit, maximizing the potential of its production capabilities. With almost 1,000 employees worldwide, the company is consolidating its position in the generics market.
Visit Company Website
